Table 2.
Demographic characteristics of pre-COVID peri-COVID patients.
| Variable | Category | Total n = 433 |
Pre-COVID n = 237 |
Peri-COVID n = 196 |
p |
|---|---|---|---|---|---|
| Gender | Men | 225 (51.9%) | 134 (56.5%) | 91 (46.4%) | 0.036 * |
| Women | 208 (48.03) | 103 (43.5%) | 105 (53.6%) | ||
| Age | Men | ||||
| mean ± SD Women |
59.44 ± 15.21 | 57.57 ± 13.43 | 62.19 ± 17.21 | 0.596 | |
| mean ± SD | 62.2 ± 18.07 | 58.78 ± 19.89 | 65.55 ± 15.45 | 0.151 | |
| Total | |||||
| mean ± SD | 60.76 ± 16.68 | 58.09 ± 19.52 | 63.99 ± 16.34 | <0.001 * | |
| Etiology | Biliary | 357 (82.4%) | 195 (82.2%) | 162 (82.6%) | 0.830 |
| Alcohol | 53 (12.2%) | 31 (13%) | 22 (11.2%) | ||
| Unknown | 23 (5.3%) | 11 (4.6%) | 12 (6.1%) | ||
| Form | Mild | 120 (27.7%) | 81 (34.1%) | 39 (19.8%) | 0.072 |
| Moderate | 184 (42.4%) | 86 (36.2%) | 98 (50.0%) | ||
| Severe | 129 (29.7%) | 70 (29.5%) | 59 (30.1%) | ||
| Hours_onset | 35.28 ± 26.4 | 32.99 ± 26.27 | 38.04 ± 26.34 | 0.047 * | |
| Hosp_days | 12.81 ± 13.31 | 14 ± 16.55 | 11.37 ± 7.58 | 0.030 * | |
| Complications | Abscess | 24 (5.5%) | 9 (3.8%) | 15(7.7%) | 0.006 * |
| Necrosis | 29 (6.7%) | 9 (3.8%) | 20 (10.2%) | ||
| Pseudocyst | 15 (3.5%) | 10 (4.2%) | 5 (2.6%) | ||
| Without | 364 (84.1%) | 208 (87.8%) | 156 (79.6%) | ||
| Treatment | Surgical | 25 (5.8%) | 16 (6.8%) | 9 (4.6%) | 0.339 |
| Medical | 408 (94.2%) | 221 (93.2%) | 187 (95.4%) | ||
| Mortality | Discharged | 60 (13.9%) | 24 (10.1%) | 36 (18.4%) | 0.016 * |
| Alive | 373 (86.1%) | 213 (89.9%) | 160 (81.6%) |
* p < 0.05—statistically significant.